| Midwest Infectious Disease Specialists Llc | |
|
19201 E Valley View Pkwy Suite G Independence MO 64055-6910 | |
| (816) 254-2552 | |
| (816) 833-4155 |
| Full Name | Midwest Infectious Disease Specialists Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 19201 E Valley View Pkwy, Independence, Missouri |
| Authorized Official Name and Position | Patrick J Kueny (VP) |
| Authorized Official Contact | 8162542552 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Midwest Infectious Disease Specialists Llc 19201 E Valley View Pkwy Suite G Independence MO 64055-6910 Ph: (816) 254-2552 | Midwest Infectious Disease Specialists Llc 19201 E Valley View Pkwy Suite G Independence MO 64055-6910 Ph: (816) 254-2552 |
| NPI Number | 1578510194 |
|---|---|
| Provider Enumeration Date | 05/28/2006 |
| Last Update Date | 03/19/2009 |
| Medicare PECOS PAC ID | 6800817453 |
|---|---|
| Medicare Enrollment ID | O20051212000543 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it completed the design of the Rheumatoid Arthritis (RA) Phase III study of its lead drug candidate CF101.
Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.
A new study sheds light on how the immune system replenishes itself during sleep. Researchers found that some subsets of T cells are reduced from the bloodstream during sleep when risk of infection is low.
Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578510194 | NPI | - | NPPES |
| 507620706 | Medicaid | MO | |
| 200590210 A | Medicaid | KS | |
| 36315014 | Other | MO | BCBS OF KC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | (* (Not Available)) | Primary |
| Provider Name | Bridget Bransteitter |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1114031580 PECOS PAC ID: 4587747910 Enrollment ID: I20080208000178 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it completed the design of the Rheumatoid Arthritis (RA) Phase III study of its lead drug candidate CF101.
Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.
A new study sheds light on how the immune system replenishes itself during sleep. Researchers found that some subsets of T cells are reduced from the bloodstream during sleep when risk of infection is low.
Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
› Verified 9 days ago
| Provider Name | Atul Gupta |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1790826063 PECOS PAC ID: 0648348193 Enrollment ID: I20081010000069 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it completed the design of the Rheumatoid Arthritis (RA) Phase III study of its lead drug candidate CF101.
Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.
A new study sheds light on how the immune system replenishes itself during sleep. Researchers found that some subsets of T cells are reduced from the bloodstream during sleep when risk of infection is low.
Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
› Verified 9 days ago
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it completed the design of the Rheumatoid Arthritis (RA) Phase III study of its lead drug candidate CF101.
Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.
A new study sheds light on how the immune system replenishes itself during sleep. Researchers found that some subsets of T cells are reduced from the bloodstream during sleep when risk of infection is low.
Kamada LTD., a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, was granted an Orphan Drug Designation for its Alpha-1 Antitrypsin (AAT) product to treat type 1 diabetes.
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
› Verified 9 days ago
Noland Family Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 514 S Noland Rd, Suite 130, Independence, MO 64050 Phone: 816-254-1781 Fax: 816-254-2182 | |
Medbasics Missouri Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4201 S Noland Rd, Independence, MO 64055 Phone: 816-373-9901 Fax: 816-373-9905 | |
Independence Group Health, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 19045 E Valley View Pkwy Ste G, Independence, MO 64055 Phone: 281-429-8526 | |
Swope Health East Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 17844 East 23rd Street, Independence, MO 64057 Phone: 816-922-1000 | |
P&c Healthcare Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 913-222-9779 | |
Jackson County Medical Group Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 17221 E 23rd St S, Suite 100, Independence, MO 64057 Phone: 816-350-0005 | |
Kc Core Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 19550 E 39th St S, Suite 235, Independence, MO 64057 Phone: 816-795-5300 Fax: 816-795-5305 |